Literature DB >> 29140185

Thrombolysis: Improving door-to-needle times for ischemic stroke treatment - A narrative review.

Noreen Kamal1, Eric E Smith1,2, Thomas Jeerakathil3, Michael D Hill1,2,4,5.   

Abstract

Background The effectiveness of thrombolysis is highly time dependent. For this reason, short target times have been set to reduce time to treatment from hospital arrival, which is called door-to-needle time. Summary of review There has been considerable work done at single centers and across multiple hospitals to improve door-to-needle time. There have been reductions of 8 to 47 min when applying one or more improvement strategies at single centers, and there have been many multi-hospital initiatives. The delays to treatment have been attributed to both patient and hospital factors, and strategies to address these delays have been proven to reduce door-to-needle time. The most effective strategies include pre-notification of arrival by Emergency Medical Services (EMS), single-call activation of stroke team, rapid registration process, moving the patient to computed tomography on EMS stretcher, and administration of alteplase in the scanner. There are many exciting areas of future direction including reduction of door-to-needle time in developing countries, improving pre-hospital response times, and improving the efficiency of endovascular treatment. Conclusions There is now a broad understanding of the causes of delays to fast treatment and the strategies that can be employed to improve door-to-needle time such that most centers could achieve median door-to-needle time of 30 min.

Entities:  

Keywords:  Acute stroke; door-to-needle; thrombolysis

Mesh:

Year:  2017        PMID: 29140185     DOI: 10.1177/1747493017743060

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  18 in total

1.  The application of the emergency green channel integrated management strategy in intravenous thrombolytic therapy for AIS.

Authors:  Hui Zhang; Bin Zhang; Jie Chen
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  A Decade of Improvement in Door-to-Needle Time Among Acute Ischemic Stroke Patients, 2008 to 2017.

Authors:  Xin Tong; Jennifer L Wiltz; Mary G George; Erika C Odom; Sallyann M Coleman King; Tiffany Chang; Xiaoping Yin; Robert K Merritt
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-12

3.  Improving Thrombolysis for Acute Ischemic Stroke: The Implementation and Evaluation of a Theory-Based Resource Integration Project in China.

Authors:  Qian Fu; Xiaojun Wang; Donglan Zhang; Lu Shi; Wei Wang; Zhangbao Guo; Ping Shan; Guohua Chen; Zhanchun Feng
Journal:  Int J Integr Care       Date:  2022-02-08       Impact factor: 5.120

4.  Thrombolytic DNT and fatality and disability rates in acute ischemic stroke: a study from Bigdata Observatory Platform for Stroke of China.

Authors:  Wen-Jun Tu; Xun-Ming Ji; Long-De Wang; Feng Yan; Bao-Hua Chao; Lin Ma
Journal:  Neurol Sci       Date:  2021-09-03       Impact factor: 3.307

Review 5.  Innovation in Systems of Care in Acute Phase of Ischemic Stroke. The Experience of the Catalan Stroke Programme.

Authors:  Rosa M Vivanco-Hidalgo; Sònia Abilleira; Mercè Salvat-Plana; Aida Ribera; Guillem Gallofré; Miquel Gallofré
Journal:  Front Neurol       Date:  2018-06-06       Impact factor: 4.003

6.  Impact of Emergency Department Crowding on Delays in Acute Stroke Care.

Authors:  Todd A Jaffe; Joshua N Goldstein; Brian J Yun; Mark Etherton; Thabele Leslie-Mazwi; Lee H Schwamm; Kori S Zachrison
Journal:  West J Emerg Med       Date:  2020-07-08

7.  Disability Adjusted Life Years due to Ischaemic Stroke Preventable by Real-Time Stroke Detection-A Cost-Utility Analysis of Hypothetical Stroke Detection Devices.

Authors:  Ludwig Schlemm
Journal:  Front Neurol       Date:  2018-10-01       Impact factor: 4.003

8.  Door-to-needle time for thrombolysis: a secondary analysis of the TIPS cluster randomised controlled trial.

Authors:  Md Golam Hasnain; Christine L Paul; John R Attia; Annika Ryan; Erin Kerr; Catherine D'Este; Alix Hall; Abul Hasnat Milton; Isobel J Hubbard; Christopher R Levi
Journal:  BMJ Open       Date:  2019-12-15       Impact factor: 2.692

9.  Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society.

Authors:  Kazunori Toyoda; Masatoshi Koga; Yasuyuki Iguchi; Ryo Itabashi; Manabu Inoue; Yasushi Okada; Kuniaki Ogasawara; Akira Tsujino; Yasuhiro Hasegawa; Taketo Hatano; Hiroshi Yamagami; Toru Iwama; Yoshiaki Shiokawa; Yasuo Terayama; Kazuo Minematsu
Journal:  Neurol Med Chir (Tokyo)       Date:  2019-12-05       Impact factor: 1.742

10.  Helsinki Stroke Model Is Transferrable With "Real-World" Resources and Reduced Stroke Thrombolysis Delay to 34 min in Christchurch.

Authors:  Teddy Y Wu; Erin Coleman; Sarah L Wright; Deborah F Mason; Jon Reimers; Roderick Duncan; Mary Griffiths; Michael Hurrell; David Dixon; James Weaver; Atte Meretoja; John N Fink
Journal:  Front Neurol       Date:  2018-04-30       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.